Farglitazar (GI-262570; GI262570) is a novel and potent PPAR-γ agonist with the potential to be used for glycemic control in type 2 diabetic patients. It can increase water and sodium reabsorption in distal nephron by stimulating the ENaC and Na,K-ATPase system.

纯度：≥98%

CAS：196808-45-4